Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings per share (EPS) is N/A as of the fiscal period ended Monday, June 30, 2025.
Reported quarterly EPS; no daily interpolation. Q2 FY2024 (2024-12-31): -0.90.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 10 comparable quarters.
EARNINGS PER SHARE (EPS)
N/A
EARNINGS PER SHARE (EPS) AVG TTM
-130.80
EARNINGS PER SHARE (EPS) AVG 3Y
-71.47
EARNINGS PER SHARE (EPS) AVG 5Y
N/A
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Moolec Science S.A.
Market Cap
$3.40M
Earnings Per Share (EPS)
N/A
TTM Avg
-130.80
3Y Avg
-71.47
5Y Avg
N/A
Market Cap
$3.34M
Earnings Per Share (EPS)
-4.90
TTM Avg
-7.69
3Y Avg
-8.41
5Y Avg
-8.41
Market Cap
$3.35M
Earnings Per Share (EPS)
-11.70
TTM Avg
-48.19
3Y Avg
-238.41
5Y Avg
-340.02
Market Cap
$3.49M
Earnings Per Share (EPS)
-0.45
TTM Avg
-1.48
3Y Avg
-5.05
5Y Avg
-8.12
Market Cap
$3.50M
Earnings Per Share (EPS)
-0.91
TTM Avg
-1.99
3Y Avg
-3.92
5Y Avg
-2.83
Market Cap
$3.29M
Earnings Per Share (EPS)
-6.76
TTM Avg
-8.05
3Y Avg
-9.85
5Y Avg
-9.67
Market Cap
$3.53M
Earnings Per Share (EPS)
-14.40
TTM Avg
-19.95
3Y Avg
-16.43
5Y Avg
-17.45
Market Cap
$3.25M
Earnings Per Share (EPS)
N/A
TTM Avg
-1108.98
3Y Avg
-1045.55
5Y Avg
-1171.01
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Moolec Science S.A. (MLEC) | $3.40M | N/A | -130.80 | -71.47 | N/A |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.34M | -4.90 | -7.69 | -8.41 | -8.41 |
| Eocene Ltd. (EOCN)vs › | $3.46M | N/A | N/A | N/A | N/A |
| Aethlon Medical, Inc. (AEMD)vs › | $3.35M | -11.70 | -48.19 | -238.41 | -340.02 |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | -0.45 | -1.48 | -5.05 | -8.12 |
| Evogene Ltd. (EVGN)vs › | $3.50M | -0.91 | -1.99 | -3.92 | -2.83 |
| IceCure Medical Ltd (ICCM)vs › | $3.29M | -6.76 | -8.05 | -9.85 | -9.67 |
| Nexalin Technology, Inc. (NXL)vs › | $3.53M | -14.40 | -19.95 | -16.43 | -17.45 |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.25M | N/A | -1108.98 | -1045.55 | -1171.01 |
| MBody AI Ltd. (MBAI)vs › | $3.21M | N/A | -12.74 | -17.52 | -18.26 |
Trailing EPS (TTM)
N/A
Forward EPS (Est.)
$6.00
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-06-30 | -258.75 |
| 2024-06-30 | -2.85 |
| 2023-06-30 | -22.50 |
| 2022-06-30 | -1.80 |
| 2021-06-30 | -0.01 |
